Trifluoroacetic Acid

Trifluoroacetic Acid

SCHEMBL4334971

CC[C@@H](NC(=N)N)C(N)=O.O=C(O)C(F)(F)F

nearest known ligand 0.37

Full drug profile on Sugi Atlas →

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
PADI4 Q9UM07 7/20 0.37
PADI1 Q9ULC6 5/20 0.37
PADI2 Q9Y2J8 3/20 0.37
CA12 O43570 4/20 0.37
CA1 P00915 4/20 0.37
CA9 Q16790 4/20 0.37
PADI3 Q9ULW8 4/20 0.36
NPY4R P50391 2/20 0.36
PDF Q9HBH1 1/20 0.34
F2 P00734 1/20 0.33
CTSS P25774 1/20 0.32
CTSK P43235 1/20 0.32
ITGB3 P05106 1/20 0.32
ITGA2B P08514 1/20 0.32
DPP8 Q6V1X1 3/20 0.31
CA2 P00918 2/20 0.31
DPP7 Q9UHL4 2/20 0.31
DPP4 P27487 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5683578 0.87 CA1 (0.34) CA12CA1CA9CA2
SCHEMBL4320263 0.87 CA1 (0.34) CA12CA1CA9CA2
Trifluoroacetic Acid SCHEMBL4334998 0.87 CA12 (0.40) PADI4PADI1PADI2CA12CA1
Trifluoroacetic Acid SCHEMBL6762932 0.87 CA12 (0.40) PADI4PADI1PADI2CA12CA1
Trifluoroacetic Acid SCHEMBL4324189 0.87 CA12 (0.40) PADI4PADI1PADI2CA12CA1
Trifluoroacetic Acid SCHEMBL15414556 0.80 PADI4 (0.34) PADI4PADI1PADI2CA12CA1
Trifluoroacetic Acid SCHEMBL6761033 0.80 CA12 (0.38) CA12CA1CA9PDFCTSS
SCHEMBL30471284 0.78 EPHX1 (0.36) PADI4PADI1PADI2CA12CA1
Trifluoroacetic Acid SCHEMBL4388550 0.78 KDM4E (0.34) PDFF2ITGB3ITGA2BDPP8
SCHEMBL29211036 0.77 TGFBR1 (0.41)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8664228-B2 3,5-diamino-6-chloro-pyrazine-2-carboxylic acid derivatives and their use as epithelial sodium channel blockers for the treatment of airway diseases NOVARTIS AG (CH) 2014-03-04 US disclosed
EP-2285785-B1 3,5-DIAMINO-6-CHLORO-PYRAZINE-2-CARBOXYLIC ACID DERIVATIVES AND THEIR USE AS EPITHELIAL SODIUM CHANNEL BLOCKERS FOR THE TREATMENT OF ARWAY DISEASES NOVARTIS AG (CH) 2012-09-05 EP disclosed
WO-2009138378-A1 3,5-DIAMINO-6-CHLORO-PYRAZINE-2-CARBOXYLIC ACID DERIVATIVES AND THEIR USE AS EPITHELIAL SODIUM CHANNEL BLOCKERS FOR THE TREATMENT OF ARWAY DISEASES NOVARTIS AG (CH) 2009-11-19 WO disclosed